Genetically Proxied Autoimmune Diseases and the Risk of Facial Aging

被引:1
|
作者
Zhang, Zhanyi [1 ]
Li, Mengyuan [2 ]
Geng, Yujia [1 ]
Wang, Wangshu [1 ]
Wang, Weihao [1 ]
Shao, Ying [1 ]
机构
[1] First Hosp Jilin Univ, Dept Plast & Cosmet Surg, Changchun 130000, Jilin, Peoples R China
[2] Jilin Agr Univ, Coll Chinese Med Mat, Changchun 130118, Jilin, Peoples R China
关键词
autoimmune disease; facial aging; Mendelian randomization; ankylosing spondylitis; systemic lupus erythematosus; celiac disease; MENDELIAN RANDOMIZATION; SUSCEPTIBILITY LOCI; ASSOCIATION; SKIN; IDENTIFICATION;
D O I
10.2147/CCID.S456126
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Purpose: Previous studies have suggested a relationship between autoimmune diseases and the risk of facial skin aging. However, evidence from population-based studies on this topic is limited, leaving the causal association between these factors unknown. This study aimed to systematically evaluate the causal effects of 18 autoimmune diseases on the risk of facial skin aging, aim of providing strategies to mitigate early facial aging in patients with autoimmune diseases. Patients and Methods: We conducted univariate Mendelian randomization (UVMR) analyses to examine the causal relationship between 18 autoimmune diseases and facial aging using publicly available summary data from genome-wide association studies (GWASs). We also conducted multivariate Mendelian randomization (MVMR) analyses to adjust for confounding factors, including smoking, alcohol consumption, and body mass index (BMI). Results: The main inverse variance weighted (IVW) method revealed that genetically proxied ankylosing spondylitis (AS) (OR 1.017; 95% CI: 1.003-1.031; P =0.018), sicca syndrome (SS) (OR 1.008; 95% CI: 1.005-1.011; P = 2.66x10 -6 ), systemic lupus erythematosus (SLE) (OR 1.006; 95% 1.001-1.011; P =0.014), multiple sclerosis (MS) (OR 1.004; 95% CI: 1.001-1.007; P =0.021), primary sclerosing cholangitis (PSC) (OR 1.002; 95% CI: 1.000-1.004; P =0.023), and celiac disease (CeD) (OR 1.002; 95% CI: 1.001-1.004; P =0.009) were significantly associated with higher risk of facial aging. After adjusting for potential confounding factors, the association persisted between AS, SLE, and CeD. Conclusion: These findings indicated that autoimmune diseases play a causal role in facial skin aging. Therefore, patients with autoimmune diseases should take appropriate measures to prevent early facial aging.
引用
收藏
页码:981 / 991
页数:11
相关论文
共 50 条
  • [31] Genetically Proxied CRP (C-Reactive Protein) Levels and Lobar Intracerebral Hemorrhage Risk
    Myserlis, Evangelos Pavlos
    Anderson, Christopher D.
    Georgakis, Marios K.
    STROKE, 2023, 54 (04) : E130 - E132
  • [32] Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
    Yarmolinsky, James
    Bouras, Emmanouil
    Constantinescu, Andrei
    Burrows, Kimberley
    Bull, Caroline J.
    Vincent, Emma E.
    Martin, Richard M.
    Dimopoulou, Olympia
    Lewis, Sarah J.
    Moreno, Victor
    Vujkovic, Marijana
    Chang, Kyong-Mi
    Voight, Benjamin F.
    Tsao, Philip S.
    Gunter, Marc J.
    Hampe, Jochen
    Pellatt, Andrew J.
    Pharoah, Paul D. P.
    Schoen, Robert E.
    Gallinger, Steven
    Jenkins, Mark A.
    Pai, Rish K.
    Gill, Dipender
    Tsilidis, Kostas K.
    DIABETOLOGIA, 2023, 66 (08) : 1481 - 1500
  • [33] Autoimmune diseases and atherothrombotic risk
    Ridker, Paul M.
    LANCET, 2022, 400 (10354): : 708 - 710
  • [34] Autoimmune diseases and cardiovascular risk
    Gelfand, Joel M.
    Wang, Sonia
    Garshick, Michael S.
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (12) : 1025 - 1027
  • [35] Autoimmune diseases as a risk factor
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (20) : 1304 - 1304
  • [36] Autoimmune diseases and the risk of cancer
    Heikkinen, Sanna
    Tanskanen, Tomas
    Sipila, Lauri
    Pitkaniemi, Janne
    CANCER RESEARCH, 2022, 82 (12)
  • [37] Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
    James Yarmolinsky
    Emmanouil Bouras
    Andrei Constantinescu
    Kimberley Burrows
    Caroline J. Bull
    Emma E. Vincent
    Richard M. Martin
    Olympia Dimopoulou
    Sarah J. Lewis
    Victor Moreno
    Marijana Vujkovic
    Kyong-Mi Chang
    Benjamin F. Voight
    Philip S. Tsao
    Marc J. Gunter
    Jochen Hampe
    Andrew J. Pellatt
    Paul D. P. Pharoah
    Robert E. Schoen
    Steven Gallinger
    Mark A. Jenkins
    Rish K. Pai
    Dipender Gill
    Kostas K. Tsilidis
    Diabetologia, 2023, 66 : 1481 - 1500
  • [38] Evaluating the association between genetically proxied ACE inhibition and dementias
    Nassan, Malik
    Daghlas, Iyas
    Piras, Ignazio S.
    Rogalski, Emily
    Reus, Lianne M.
    Pijnenburg, Yolande
    Cuddy, Leah K.
    Saxena, Richa
    Mesulam, M-Marsel
    Huentelman, Matt
    ALZHEIMERS & DEMENTIA, 2023, 19 (09) : 3894 - 3901
  • [39] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
    Yarmolinsky, James
    Diez-Obrero, Virginia
    Richardson, Tom M.
    Pigeyre, Marie E.
    Sjaarda, Jennifer Y.
    Pare, Guillaume
    Walker, Venexia
    Vincent, Emma
    Tan, Vanessa
    Obon-Santacana, Mireia
    Albanes, Demetrius K.
    Hampe, Jochen
    Gsur, Andrea
    Hampel, Heather
    Pai, Rish
    Jenkins, Mark I.
    Gallinger, Steven
    Casey, Graham M.
    Zheng, Wei
    Amos, Christopher
    Smith, George Davey
    Martin, Richard
    Moreno, Victor
    PRACTICAL consortium
    MEGASTROKE consortium
    PLOS MEDICINE, 2022, 19 (02)
  • [40] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis
    Yao, Zehui
    Qin, Dailei
    Cao, Jianzhong
    Gao, Chun
    Xi, Pu
    Li, Shengping
    Wei, Ran
    BMC CANCER, 2025, 25 (01)